Published in Circ Res on August 03, 2001
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest (2005) 5.53
Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res (2012) 2.38
Aldosterone-induced inflammation in the rat heart : role of oxidative stress. Am J Pathol (2002) 2.33
Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circ Res (2008) 2.24
Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J (2003) 2.11
NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest (2005) 1.94
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev (2007) 1.86
Oxidative stress as a mediator of cardiovascular disease. Oxid Med Cell Longev (2010) 1.58
Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol (2005) 1.42
Mitochondrial centrality in heart failure. Heart Fail Rev (2008) 1.28
Oxidative stress and apoptosis in heart failure progression. Circ Res (2001) 1.25
In-home solid fuel use and cardiovascular disease: a cross-sectional analysis of the Shanghai Putuo study. Environ Health (2012) 1.24
Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci U S A (2002) 1.21
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy. J Am Coll Cardiol (2015) 1.14
Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. Circ Res (2003) 1.10
Cardiac autonomic dysfunction from occupational exposure to polycyclic aromatic hydrocarbons. Occup Environ Med (2010) 1.05
Apoptosis predominates in nonmyocytes in heart failure. Am J Physiol Heart Circ Physiol (2009) 1.02
Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy. Circ Res (2010) 1.02
Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase. Cardiovasc Pathol (2008) 1.01
A matter of life and death: cardiac myocyte apoptosis and regeneration. J Clin Invest (2003) 0.97
Macro- and micronutrients in African-Americans with heart failure. Heart Fail Rev (2006) 0.95
Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. J Diabetes Investig (2014) 0.94
Adrenergic signaling and oxidative stress: a role for sirtuins? Front Physiol (2013) 0.93
CaMKII in sinoatrial node physiology and dysfunction. Front Pharmacol (2014) 0.92
Distinct signaling functions for Shc isoforms in the heart. J Biol Chem (2006) 0.92
Mitochondria in heart failure: the emerging role of mitochondrial dynamics. Heart Fail Rev (2013) 0.90
The role of SUMO-1 in cardiac oxidative stress and hypertrophy. Antioxid Redox Signal (2014) 0.90
Congestive heart failure: where homeostasis begets dyshomeostasis. J Cardiovasc Pharmacol (2010) 0.88
Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease. Antioxid Redox Signal (2012) 0.87
Sleep is not just for the brain: transcriptional responses to sleep in peripheral tissues. BMC Genomics (2013) 0.86
Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy. J Cell Mol Med (2012) 0.84
Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism--a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia. Biochim Biophys Acta (2006) 0.83
Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy. PLoS One (2013) 0.83
Oxidative stress is involved in the pathogenesis of Keshan disease (an endemic dilated cardiomyopathy) in China. Oxid Med Cell Longev (2013) 0.83
Persistence of apoptosis and inflammatory responses in the heart and bone marrow of mice following whole-body exposure to ²⁸Silicon (²⁸Si) ions. Radiat Environ Biophys (2013) 0.82
Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects. FASEB J (2012) 0.82
Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis. Biochim Biophys Acta (2014) 0.81
Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance. Front Biosci (Landmark Ed) (2009) 0.81
Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology. PLoS One (2015) 0.80
Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol (2014) 0.80
Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies. Heart Fail Rev (2012) 0.80
Cardiovascular determinants of life span. Pflugers Arch (2009) 0.80
Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53. Heart Vessels (2016) 0.80
Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity. PLoS One (2014) 0.79
p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis. Mol Cancer (2015) 0.79
Cardiac remodeling and physical training post myocardial infarction. World J Cardiol (2015) 0.77
N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure. Physiol Rep (2016) 0.77
Effect of the degree of ischaemic injury and reoxygenation time on the type of myocardial cell death in man: role of caspases. BMC Physiol (2005) 0.77
Oxidative modulation of marcaine and lekoptin in H9C2 rat myoblasts. Acta Pharmacol Sin (2009) 0.77
Inhibition of adenylyl cyclase type 5 increases longevity and healthful aging through oxidative stress protection. Oxid Med Cell Longev (2015) 0.77
Pathologic Manifestations on Surgical Biopsy and Their Correlation with Clinical Indices in Dogs with Degenerative Mitral Valve Disease. J Vet Intern Med (2015) 0.76
Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications. Biomed Res Int (2014) 0.76
Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome: Still a myth or a fact that needs exploration? J Saudi Heart Assoc (2015) 0.76
Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling. Circ Res (2016) 0.76
TNF-alpha-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy. J Cell Mol Med (2009) 0.76
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology. Oxid Med Cell Longev (2016) 0.75
Effect of acute xanthine oxidase inhibition on myocardial energetics during basal and very high cardiac workstates. J Cardiovasc Transl Res (2011) 0.75
Novel Insights into the PKCβ-dependent Regulation of the Oxidoreductase p66Shc. J Biol Chem (2016) 0.75
A Novel Class of Human Cardiac Stem Cells. Cardiol Rev (2015) 0.75
Spontaneous Dilated Cardiomyopathy and Right-Sided Heart Failure as a Differential Diagnosis for Hepatosis Dietetica in a Production Pig. Comp Med (2015) 0.75
Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data. BMC Med (2017) 0.75
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis. Biomed Res Int (2013) 0.75
Reduced pulmonary function is age-dependent in the rat lung in normoxia. Eur J Med Res (2010) 0.75
Myocardial oxidative damage is induced by cardiac Fas-dependent and mitochondria-dependent apoptotic pathways in human cocaine-related overdose. Sci Rep (2017) 0.75
Identification of cardioprotective agents from traditional Chinese medicine against oxidative damage. Mol Med Rep (2016) 0.75
Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair. JACC Basic Transl Sci (2017) 0.75
Recent advances of adapter proteins in the regulation of heart diseases. Heart Fail Rev (2017) 0.75
Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy. J Cell Mol Med (2017) 0.75
Sequential radial and circumferential strain and oxidative stress assessment in dogs with tachycardia-induced cardiac dysfunction. Int J Cardiovasc Imaging (2015) 0.75
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med (2001) 10.03
Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19
Apoptosis in the failing human heart. N Engl J Med (1997) 6.35
Alternative splicing in the control of gene expression. Annu Rev Genet (1989) 6.18
Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu Rev Biochem (1987) 5.79
Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell (1993) 4.90
Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol Cell Biol (1986) 4.46
Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes Dev (1991) 4.28
Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A (1988) 4.23
Scanning from an independently specified branch point defines the 3' splice site of mammalian introns. Nature (1989) 4.18
Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev (1992) 4.10
Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem (1984) 4.01
Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell (1978) 3.96
Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A (1986) 3.83
Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev (1993) 3.63
Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell (1993) 3.42
Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest (1996) 3.42
Myocyte death in the failing human heart is gender dependent. Circ Res (1999) 3.38
Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res (1991) 3.32
Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation (1994) 3.24
Moloney murine sarcoma proviral DNA is a transcriptional unit. Nature (1980) 3.13
Myocardial cell death in human diabetes. Circ Res (2000) 3.12
Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci U S A (1984) 3.05
Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science (1994) 3.05
Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene. Cell (1985) 3.02
Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns. Mol Cell Biol (1993) 2.98
Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest (1997) 2.93
Mutually exclusive splicing of alpha-tropomyosin exons enforced by an unusual lariat branch point location: implications for constitutive splicing. Cell (1989) 2.84
A muscle-specific enhancer is located at the 3' end of the myosin light-chain 1/3 gene locus. Genes Dev (1988) 2.71
Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res (1994) 2.64
Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A (1998) 2.60
All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science (1986) 2.57
Fast skeletal muscle myosin light chains 1 and 3 are produced from a single gene by a combined process of differential RNA transcription and splicing. J Biol Chem (1984) 2.49
Gender differences and aging: effects on the human heart. J Am Coll Cardiol (1995) 2.49
Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res (2001) 2.43
hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol Cell Biol (1993) 2.41
Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment. Cell (1983) 2.37
Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest (1987) 2.37
Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A (1996) 2.34
Molecular characterization of two myosin heavy chain genes expressed in the adult heart. Nature (1982) 2.28
Gating mechanism of a cloned potassium channel expressed in frog oocytes and mammalian cells. Neuron (1990) 2.20
Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci (2001) 2.17
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res (1998) 2.16
A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development (1993) 2.13
Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res (1998) 2.11
Incremental reductions of positive charge within the S4 region of a voltage-gated K+ channel result in corresponding decreases in gating charge. Neuron (1992) 2.09
MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc Natl Acad Sci U S A (1993) 2.07
Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice. Genes Dev (1991) 2.07
Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol (1996) 2.06
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol (1996) 2.05
Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science (1994) 2.02
Stretch-induced programmed myocyte cell death. J Clin Invest (1995) 1.99
Generation of protein isoform diversity by alternative splicing: mechanistic and biological implications. Annu Rev Cell Biol (1987) 1.97
Complete nucleotide and encoded amino acid sequence of a mammalian myosin heavy chain gene. Evidence against intron-dependent evolution of the rod. J Mol Biol (1986) 1.97
Alpha-tropomyosin gene organization. Alternative splicing of duplicated isotype-specific exons accounts for the production of smooth and striated muscle isoforms. J Biol Chem (1987) 1.96
Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res (1996) 1.95
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes (2001) 1.92
Smooth muscle-specific switching of alpha-tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon. EMBO J (1994) 1.91
Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation (1998) 1.90
Co-expression of multiple myosin heavy chain genes, in addition to a tissue-specific one, in extraocular musculature. J Cell Biol (1985) 1.90
The rat alpha-tropomyosin gene generates a minimum of six different mRNAs coding for striated, smooth, and nonmuscle isoforms by alternative splicing. Mol Cell Biol (1988) 1.89
Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res (1990) 1.85
Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem (1989) 1.83
Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res (2001) 1.83
Transcriptional and cell cycle-mediated regulation of myosin heavy chain gene expression during muscle cell differentiation. J Biol Chem (1983) 1.82
A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways. Mol Cell Biol (1991) 1.80
Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning. J Biol Chem (1988) 1.75
Multigene family for sarcomeric myosin heavy chain in mouse and human DNA: localization on a single chromosome. Science (1983) 1.74